Eiko Lifesciences Ltd - 540204 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E January 17, 2023
The Board considered and approved the Unaudited Financial Results for the Quarter and nine months ended 31st December, 2022 Eiko Lifesciences Ltd - 540204 - Board Meeting Intimation for Approval Of Unaudited Financial Results Of The Company For The Quarter And Nine Month Ended December 31, 2022
Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/01/2023 ,inter alia, to consider and approve unaudited financial results of the Company for the quarter and Nine month ended December 31, 2022 Eiko Lifesciences Ltd - 540204 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2022. Eiko Lifesciences Ltd - 540204 - Closure of Trading Window
This is to inform that as per the Internal Code of Conduct for Regulating, Monitoring and Reporting of Trades by Designated Persons of Eiko Lifesciences Limited (''the Company'') read with applicable provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 (including any amendment(s), modification(s) or re-enactment(s) thereto), the Trading Window for dealing in securities of the Company by Designated Persons and their immediate relatives shall remain closed from Sunday, January 01, 2023 till 48 hours after the declaration of Unaudited Financial Results of the Company for the Third Quarter ending December 31, 2022. The date of announcement of the Financial Results shall be informed in due course. Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Laxmikant Kabra HUF Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Laxmikant Kabra HUF Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Laxmikant Kabra (HUF) Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Laxmikant Kabra HUF Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Laxmikant Kabra HUF